# Imax Corp: filings

IMAX · NYSE · CIK 921582 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/imax.md) · [Financials](/companies/imax/financials.md) · [Filings](/companies/imax/filings.md) · [Insiders](/companies/imax/insiders.md)

## Reports and events: 279 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 817, 8-K 176, 10-Q 53, 144 43, SC 13G/A 39, 3 35, SC 13G 27, DEF 14A 19, 10-K 18, UPLOAD 18, SCHEDULE 13G/A 17, SD 13, CORRESP 12, SC 13D/A 9, 4/A 7, S-8 POS 7, S-8 5, SCHEDULE 13G 5, ARS 4, PRE 14A 4, FWP 3, 144/A 2, 424B2 2, 424B5 2, S-3 2, S-3ASR 2, SCHEDULE 13D/A 2, 11-K 1, 25 1, 3/A 1, 425 1, 8-A12B 1, 8-K/A 1, CERTNYS 1, EFFECT 1, RW 1, S-3/A 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-21 | 20:11 ET | [8-K](/filings/0001628280-26-058427.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-058427 |
| 2026-07-23 | 12:47 ET | [10-Q](/filings/0001628280-26-049300.md) | Quarterly report, period 2026-06-30 | 0001628280-26-049300 |
| 2026-07-23 | 12:05 ET | [8-K](/filings/0001628280-26-049290.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-049290 |
| 2026-06-11 | 20:13 ET | [8-K](/filings/0001628280-26-042508.md) | 5.07 Shareholder vote results | 0001628280-26-042508 |
| 2026-04-30 | 20:45 ET | [10-Q](/filings/0001628280-26-028960.md) | Quarterly report, period 2026-03-31 | 0001628280-26-028960 |
| 2026-04-30 | 20:16 ET | [8-K](/filings/0001628280-26-028907.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-028907 |
| 2026-04-24 | 20:19 ET | [DEF 14A](/filings/0001628280-26-027220.md) | Proxy statement, period 2026-06-10 | 0001628280-26-027220 |
| 2026-04-17 | 20:17 ET | [8-K](/filings/0001628280-26-025752.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-025752 |
| 2026-03-30 | 21:33 ET | [8-K](/filings/0001628280-26-022043.md) | 7.01 Regulation FD disclosure | 0001628280-26-022043 |
| 2026-03-17 | 21:00 ET | [SCHEDULE 13D/A](/filings/0001193125-26-111118.md) | Ownership report, active investor, amended | 0001193125-26-111118 |
| 2026-02-25 | 22:03 ET | [10-K](/filings/0001628280-26-011770.md) | Annual report, period 2025-12-31 | 0001628280-26-011770 |
| 2026-02-25 | 21:24 ET | [8-K](/filings/0001628280-26-011693.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-011693 |
| 2026-01-23 | 21:00 ET | [SCHEDULE 13D/A](/filings/0001193125-26-021015.md) | Ownership report, active investor, amended | 0001193125-26-021015 |
| 2025-11-06 | 22:02 ET | [8-K](/filings/0001193125-25-270049.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-270049 |
| 2025-10-23 | 12:43 ET | [10-Q](/filings/0001628280-25-045982.md) | Quarterly report, period 2025-09-30 | 0001628280-25-045982 |
| 2025-10-23 | 12:07 ET | [8-K](/filings/0001628280-25-045977.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-045977 |
| 2025-07-24 | 12:50 ET | [10-Q](/filings/0000921582-25-000067.md) | Quarterly report, period 2025-06-30 | 0000921582-25-000067 |
| 2025-07-24 | 12:08 ET | [8-K](/filings/0000921582-25-000064.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000921582-25-000064 |
| 2025-07-17 | 20:19 ET | [8-K](/filings/0000921582-25-000054.md) | 5.02 Departure or appointment of officers or directors | 0000921582-25-000054 |
| 2025-07-15 | 12:30 ET | [8-K](/filings/0001193125-25-159091.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-25-159091 |
| 2025-06-13 | 20:21 ET | [8-K](/filings/0000921582-25-000046.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure | 0000921582-25-000046 |
| 2025-04-25 | 20:28 ET | [8-K](/filings/0000921582-25-000039.md) | 5.02 Departure or appointment of officers or directors | 0000921582-25-000039 |
| 2025-04-25 | 20:16 ET | [DEF 14A](/filings/0000921582-25-000033.md) | Proxy statement, period 2025-06-11 | 0000921582-25-000033 |
| 2025-04-23 | 21:03 ET | [10-Q](/filings/0000921582-25-000025.md) | Quarterly report, period 2025-03-31 | 0000921582-25-000025 |
| 2025-04-23 | 20:15 ET | [8-K](/filings/0000921582-25-000022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000921582-25-000022 |
| 2025-02-19 | 22:22 ET | [10-K](/filings/0000921582-25-000008.md) | Annual report, period 2024-12-31 | 0000921582-25-000008 |
| 2025-02-19 | 21:09 ET | [8-K](/filings/0000921582-25-000005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000921582-25-000005 |
| 2025-01-17 | 13:00 ET | [8-K](/filings/0001193125-25-008067.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-008067 |
| 2024-10-30 | 21:14 ET | [10-Q](/filings/0000921582-24-000022.md) | Quarterly report, period 2024-09-30 | 0000921582-24-000022 |
| 2024-10-30 | 20:15 ET | [8-K](/filings/0000921582-24-000018.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000921582-24-000018 |
| 2024-09-16 | 20:21 ET | [8-K](/filings/0001193125-24-219620.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-219620 |
| 2024-07-25 | 12:51 ET | [10-Q](/filings/0000921582-24-000010.md) | Quarterly report, period 2024-06-30 | 0000921582-24-000010 |
| 2024-07-25 | 12:04 ET | [8-K](/filings/0000921582-24-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000921582-24-000006 |
| 2024-06-17 | 20:10 ET | [SC 13D/A](/filings/0001193125-24-162610.md) | Ownership report, active investor, amended | 0001193125-24-162610 |
| 2024-06-07 | 20:17 ET | [8-K](/filings/0001193125-24-157387.md) | 5.07 Shareholder vote results | 0001193125-24-157387 |
| 2024-04-26 | 20:21 ET | [DEF 14A](/filings/0000950170-24-049184.md) | Proxy statement, period 2024-04-26 | 0000950170-24-049184 |
| 2024-04-25 | 12:31 ET | [10-Q](/filings/0000950170-24-047943.md) | Quarterly report, period 2024-03-31 | 0000950170-24-047943 |
| 2024-04-25 | 11:30 ET | [8-K](/filings/0000950170-24-047922.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-047922 |
| 2024-02-27 | 22:01 ET | [10-K](/filings/0000950170-24-021327.md) | Annual report, period 2023-12-31 | 0000950170-24-021327 |
| 2024-02-27 | 21:24 ET | [8-K](/filings/0000950170-24-021210.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-021210 |
| 2024-01-25 | 21:30 ET | [SC 13D/A](/filings/0001193125-24-015449.md) | Ownership report, active investor, amended | 0001193125-24-015449 |
| 2023-10-25 | 14:01 ET | [10-Q](/filings/0000950170-23-055032.md) | Quarterly report, period 2023-09-30 | 0000950170-23-055032 |
| 2023-10-25 | 12:06 ET | [8-K](/filings/0000950170-23-055006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-055006 |
| 2023-07-26 | 21:01 ET | [10-Q](/filings/0000950170-23-034792.md) | Quarterly report, period 2023-06-30 | 0000950170-23-034792 |
| 2023-07-26 | 20:14 ET | [8-K](/filings/0000950170-23-034726.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-034726 |
| 2023-07-13 | 22:30 ET | [8-K](/filings/0001193125-23-186051.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-186051 |
| 2023-06-14 | 20:30 ET | [8-K](/filings/0001193125-23-166895.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-166895 |
| 2023-04-27 | 21:01 ET | [10-Q](/filings/0000950170-23-015371.md) | Quarterly report, period 2023-03-31 | 0000950170-23-015371 |
| 2023-04-27 | 20:10 ET | [8-K](/filings/0000950170-23-015274.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-015274 |
| 2023-04-26 | 20:17 ET | [DEF 14A](/filings/0000950170-23-014821.md) | Proxy statement | 0000950170-23-014821 |

Page 1 of 6. [Older](/companies/imax/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.